Skip to Content

93 7455 (Glipizide and Metformin Hydrochloride 2.5 mg / 250 mg)

Pill with imprint 93 7455 is Pink, Elliptical / Oval and has been identified as Glipizide and Metformin Hydrochloride 2.5 mg / 250 mg. It is supplied by Teva Pharmaceuticals USA.

Glipizide/metformin is used in the treatment of diabetes, type 2 and belongs to the drug class antidiabetic combinations. Risk cannot be ruled out during pregnancy. Glipizide/metformin 2.5 mg / 250 mg is not a controlled substance under the Controlled Substances Act (CSA).

Images for 93 7455

Glipizide and metformin hydrochloride 2.5 mg / 250 mg 93 7455
Glipizide and metformin hydrochloride 2.5 mg / 250 mg 93 7455 Front
Glipizide and metformin hydrochloride 2.5 mg / 250 mg 93 7455 Back
Glipizide and metformin hydrochloride 2.5 mg / 250 mg 93 7455

Glipizide and Metformin Hydrochloride

Imprint:
93 7455
Strength:
2.5 mg / 250 mg
Color:
Pink
Size:
13.00 mm
Shape:
Elliptical / Oval
Availability:
Prescription only
Drug Class:
Antidiabetic combinations
Pregnancy Category:
C - Risk cannot be ruled out
CSA Schedule:
Not a controlled drug
Labeler / Supplier:
Teva Pharmaceuticals USA
Inactive Ingredients:
corn starch
croscarmellose sodium
magnesium stearate
microcrystalline cellulose
polyethylene glycol
polyvinyl alcohol
povidone k30
magnesium silicate
titanium dioxide
ferrosoferric oxide
ferric oxide red
ferric oxide yellow
Note: Inactive ingredients may vary.

Get help with Imprint Code FAQs.

Further information

Always consult your healthcare provider to ensure the information displayed on this page applies to your personal circumstances.

Hide